Zhitong Financial APP News, Star Lake Technology (600866.SH) announcement, recently, the company's director and deputy general manager Yan Xiaolong and Yan Xiaolin did not agree with the issue price, so they did not sign the "Guangdong Zhaoqing Xinghu Biotechnology Co., Ltd. issued shares and paid cash to purchase assets and raise supporting funds and related transactions" and other relevant documents. The company failed to complete the submission of the underwriting summary document of the stock issue to a specific target in time ("this issue"), combined with the current situation of the capital market and the actual situation of the company, after careful study by the company's board of directors, decided to terminate the company's offering.
The announcement shows that the termination of this issue will not have a substantial impact on the normal operation of the company, nor will it affect the implementation of the company issuing shares and paying cash to buy 99.22% of the shares of Ipin Biology, which does not constitute a major adjustment to the trading plan.